Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma

NCT06884683 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Metformin

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS